<DOC>
	<DOC>NCT01731990</DOC>
	<brief_summary>This study is designed to assess the safety, tolerability and efficacy of ACZ885 on the leg artery structure and physical activity in patients with atherosclerotic peripheral artery disease and leg pain from walking.</brief_summary>
	<brief_title>Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Intermittent Claudication</mesh_term>
	<criteria>Must have a signed informed consent form. Must be between the ages of 18 and 80 Must experience leg pain associated with walking when walking less than 400 meters and have an ankle brachial index between 0.50 and 0.85 Must be on stable asprin and statin doses for at least 6 weeks Blood pressure within ranges specificed in the protocol Able to communicate well with the Investigator and understand and comply with the study procedures Recent use of any other experimental drugs Pregnant or nursing women Women of child bearing potential unless willing to use contraception as detailed in the protocol Cannot walk 50 meters People on restricted medications as listed in the protocol Any open or nonhealing wounds with 3 months of study start or infection within 2 weeks or study start Significant heart disease Uncontrolled diabetes Significant kidney or liver disease Live vaccinations with 3 months of study start History of untreated tuberculosis or active tuberculosis (TB) Patients with metal in their body (excluded due to MRI scan) as detailed in the protocol.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Peripheral artery disease</keyword>
	<keyword>Intermittent claudication</keyword>
	<keyword>magnetic resonance imaging</keyword>
</DOC>